Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Dale Berry, M.D.

Co-Author

This page shows the publications co-authored by James Berry and Sabrina Paganoni.
Connection Strength

4.858
  1. Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis. Muscle Nerve. 2019 08; 60(2):147-154.
    View in: PubMed
    Score: 0.822
  2. Developing multidisciplinary clinics for neuromuscular care and research. Muscle Nerve. 2017 Nov; 56(5):848-858.
    View in: PubMed
    Score: 0.724
  3. Outcome measures in amyotrophic lateral sclerosis clinical trials. Clin Investig (Lond). 2014; 4(7):605-618.
    View in: PubMed
    Score: 0.562
  4. Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development. Ann Neurol. 2022 02; 91(2):165-175.
    View in: PubMed
    Score: 0.245
  5. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale. Amyotroph Lateral Scler Frontotemporal Degener. 2021 11; 22(7-8):467-477.
    View in: PubMed
    Score: 0.232
  6. Smartphone data during the COVID-19 pandemic can quantify behavioral changes in people with ALS. Muscle Nerve. 2021 02; 63(2):258-262.
    View in: PubMed
    Score: 0.227
  7. Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis. Muscle Nerve. 2021 01; 63(1):31-39.
    View in: PubMed
    Score: 0.226
  8. Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. N Engl J Med. 2020 09 03; 383(10):919-930.
    View in: PubMed
    Score: 0.223
  9. Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis. J Neurol. 2020 Jun; 267(6):1754-1759.
    View in: PubMed
    Score: 0.215
  10. Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one center. Muscle Nerve. 2019 08; 60(2):137-140.
    View in: PubMed
    Score: 0.205
  11. Design and results of a smartphone-based digital phenotyping study to quantify ALS progression. Ann Clin Transl Neurol. 2019 May; 6(5):873-881.
    View in: PubMed
    Score: 0.202
  12. Experience with telemedicine in a multi-disciplinary ALS clinic. Amyotroph Lateral Scler Frontotemporal Degener. 2018 02; 19(1-2):143-148.
    View in: PubMed
    Score: 0.185
  13. Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability. Muscle Nerve. 2017 Dec; 56(6):1077-1084.
    View in: PubMed
    Score: 0.181
  14. Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational Studies. JMIR Mhealth Uhealth. 2022 02 04; 10(2):e31877.
    View in: PubMed
    Score: 0.062
  15. Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism. J Med Internet Res. 2021 12 07; 23(12):e28021.
    View in: PubMed
    Score: 0.061
  16. Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial. Neuroimage Clin. 2021; 30:102672.
    View in: PubMed
    Score: 0.058
  17. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Neurol. 2021 02 01; 78(2):186-196.
    View in: PubMed
    Score: 0.057
  18. Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic. Amyotroph Lateral Scler Frontotemporal Degener. 2021; 22(sup1):22-32.
    View in: PubMed
    Score: 0.057
  19. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle Nerve. 2020 09; 62(3):321-326.
    View in: PubMed
    Score: 0.055
  20. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities. Muscle Nerve. 2020 08; 62(2):182-186.
    View in: PubMed
    Score: 0.055
  21. Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis. Sci Rep. 2019 11 27; 9(1):17728.
    View in: PubMed
    Score: 0.053
  22. Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. BMC Neurol. 2019 May 29; 19(1):104.
    View in: PubMed
    Score: 0.051
  23. Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology. 2019 04 30; 92(18):e2089-e2100.
    View in: PubMed
    Score: 0.051
  24. Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis. Neurology. 2019 04 30; 92(18):e2081-e2088.
    View in: PubMed
    Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.